These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23740127)

  • 1. Hybrid polymeric nanoparticles: potential candidate for ophthalmic delivery.
    Bharali DJ; Armstrong D; Mousa SA
    Methods Mol Biol; 2013; 1028():279-86. PubMed ID: 23740127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of PLGA-mannosamine nanoparticles as oral protein carriers.
    Alonso-Sande M; des Rieux A; Fievez V; Sarmento B; Delgado A; Evora C; Remuñán-López C; Préat V; Alonso MJ
    Biomacromolecules; 2013 Nov; 14(11):4046-52. PubMed ID: 24131254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application.
    Yoncheva K; Vandervoort J; Ludwig A
    Pharm Dev Technol; 2011 Feb; 16(1):29-35. PubMed ID: 20038266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nose to brain delivery in rats: Effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization.
    Bonaccorso A; Musumeci T; Serapide MF; Pellitteri R; Uchegbu IF; Puglisi G
    Colloids Surf B Biointerfaces; 2017 Jun; 154():297-306. PubMed ID: 28363190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid polymeric hydrogels for ocular drug delivery: nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate.
    Barbu E; Verestiuc L; Iancu M; Jatariu A; Lungu A; Tsibouklis J
    Nanotechnology; 2009 Jun; 20(22):225108. PubMed ID: 19433871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J; Chen XG; Peng WB; Liu CS
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
    J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
    Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
    Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro evaluation of surface-modified poly (lactide-co-glycolide) microparticles as biodegradable drug carriers for pulmonary peptide and protein delivery.
    Devrim B; Bozkır A
    J Microencapsul; 2014; 31(4):355-62. PubMed ID: 24697171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of alginate, chitosan and cellulose nanocrystals as emulsion stabilizers in the synthesis of biodegradable polymeric nanoparticles.
    Rescignano N; Fortunati E; Armentano I; Hernandez R; Mijangos C; Pasquino R; Kenny JM
    J Colloid Interface Sci; 2015 May; 445():31-39. PubMed ID: 25596366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents.
    Kumar MN; Mohapatra SS; Kong X; Jena PK; Bakowsky U; Lehr CM
    J Nanosci Nanotechnol; 2004 Nov; 4(8):990-4. PubMed ID: 15656192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.